Table 2.
Summary data on observed copy number variations
# | Pathogenic (%) | Benign (%) | Unknown (%) | Log2 range | Size range (bp) | |
---|---|---|---|---|---|---|
Gains | 438 | 321 (73.3%) | 24 (5.5%) | 93 (21.2%) | 0.22 -- 2.82 | 20,486–155,171,772 |
Losses | 251 | 162 (64.5%) | 26 (10.4%) | 63 (25.1%) | −3.62 -- -0.25 | 23,615–127,293,063 |
2/64 samples without CNVs: male, oropharynx, stage IVA, pT4pN2, survival time 45 months; female, tongue, stage II, pT2pN0, alive after 40 months